Novak Alfred J - Insider Non-Derivative Transactions at Pasithea Therapeutics Corp. (KTTA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 13, 2024, Novak Alfred J's relationship to Pasithea Therapeutics Corp. (KTTA) is Director, and currently has 3,500 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KTTA insiders.
Data Source: SEC.
Novak Alfred J - Insider Non-Derivative Transactions of KTTA Common Stock
Novak Alfred J - Insider Non-Derivative Transactions at KTTA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 14, 2024 | Acquisition -- (Common Stock) | 2750 | 5.62 | 3500 |
| Jun 13, 2024 | Acquisition -- (Common Stock) | 750 | 5.61 | 750 |